Azenta Life Sciences (AZTA): רווח נקי למניה (EPS TTM)

Net income per share over the last four quarters demonstrates the effect of rental payments for DNA storage and software, where the -3.63 mark indicates the yield level. High barriers to entry due to complex robotics and optimized cryogenic system supply chains ensure Azenta, Inc. (AZTA) maintains a stable position in the medical equipment sector.

This metric reflects the operational efficiency of Azenta, Inc. (AZTA) through the lens of equity income, measuring net income adjusted for the number of shares outstanding over a rolling year. Assessing this parameter clarifies how the costly cryogenic logistics of Azenta, Inc. (AZTA) impact final profitability, which is clearly evidenced by this chart of net income per share over 12 months.